Get the Stockscreener App
76.27
0.17%
0.0618
Overview
News
Price History
Option Chain
Why AZN Down?
Discussions
Forecast
Stock Split
Dividend History
Astrazeneca PLC Stock (AZN) Latest News
AstraZeneca And GSK Put Spotlight On Nasal Polyps Space - Citeline News & Insights
Amgen-AstraZeneca Partnered Asthma Drug Shows Rapid And Sustained Effect In Chronic Rhinosinusitis - Benzinga
AstraZeneca reports total voting rights as of February end - Investing.com
AstraZeneca Announces Share Capital and Voting Rights Update - TipRanks
Severe Asthma Market Expected to rise, 2034 | AstraZeneca plc, - openPR
Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP - Yahoo Finance
CDSCO nod to AstraZeneca Pharma India to import, sell cancer treatment medicine - Medical Dialogues
AstraZeneca: CHMP recommends Imfinzi in lung cancer -March 03, 2025 at 04:31 am EST - Marketscreener.com
AstraZeneca: Tezspire effective against rhino-sinusitis -March 03, 2025 at 04:08 am EST - Marketscreener.com
Market news - Research the market
AstraZeneca's Imfinzi gets recommended for fresh EU approval - ShareCast
Viavi to buy Spirent's ethernet business, AstraZeneca's Imfinzi gets fresh EU recommendation - ShareCast
AZN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that AstraZeneca PLC Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Is AstraZeneca PLC (AZN) The Best Immunology Stock To Buy Now? - Insider Monkey
AstraZeneca, Amgen Drug Exhibits Treatment Signs in Nasal Polyps Trials -March 02, 2025 at 06:30 am EST - Marketscreener.com
Is AstraZeneca PLC (AZN) the Best Weight Loss Drug Stock to Buy According to Analysts? - Insider Monkey
Flputnam Investment Management Co. Has $19.24 Million Position in AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Dynasty Wealth Management LLC Purchases Shares of 12,012 AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Oppenheimer Asset Management Inc. Purchases 10,653 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
Proficio Capital Partners LLC Buys 697,801 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
NewEdge Wealth LLC Raises Stake in AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
JFG Wealth Management LLC Purchases Shares of 3,506 AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
AstraZeneca PLC (NASDAQ:AZN) Shares Bought by Altrius Capital Management Inc - MarketBeat
AstraZeneca’s Enhertu gains CHMP nod for breast cancer - Investing.com India
EU backs AstraZeneca, Daiichi's Enhertu for breast cancer treatment post endocrine therapy - Reuters
AstraZeneca: Enhertu recommended for approval in the EU -February 28, 2025 at 09:48 am EST - Marketscreener.com
Shareholder Rights Advocates at Levi & Korsinsky Investigate AstraZeneca PLC (AZN) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Whipplewood Advisors LLC Purchases New Holdings in AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
AstraZeneca Partnership Opens UK Biomethane Plant for Clean Energy -February 28, 2025 at 12:48 am EST - Marketscreener.com
SERD-ified progress: Astrazeneca, others advance in breast cancer - BioWorld Online
AstraZeneca opens biomethane plant in UK to cut emissions - Reuters
GSK abandons diversity targets following Trump pressure - Reuters
Non-Small Cell Lung Cancer Market Set for Significant Growth Across the 7MM During the Study Period (2025-2034) Due to the Rising Novel Therapeutic Options | DelveInsight - GlobeNewswire Inc.
AstraZeneca’s Oral SERD Is First To Succeed In Frontline Breast Cancer - Citeline News & Insights
AstraZeneca’s next breast cancer drug; Madrigal’s accelerating MASH launch - BioPharma Dive
AstraZeneca PLC (AZN): One of the Best Vaccine Stocks to Buy According to Hedge Funds - Insider Monkey
Emergency meeting to be held over Liverpool AstraZeneca blow - Liverpool Echo
Astrazeneca Says Interim Data From Breast Cancer Therapy Study Shows Promise -February 26, 2025 at 09:00 am EST - Marketscreener.com
AstraZeneca posts trial win for breast cancer drug (AZN:NASDAQ) - Seeking Alpha
AstraZeneca reports breakthrough in breast cancer treatment - Investing.com India
AstraZeneca therapy improves breast cancer survival in key trial -February 26, 2025 at 06:46 am EST - Marketscreener.com
AstraZeneca breast cancer drug shows positive results, shares up By Investing.com - Investing.com UK
AstraZeneca reports breakthrough in breast cancer treatment By Investing.com - Investing.com UK
AstraZeneca Breast Cancer Pill Delayed Disease Progression - Bloomberg
AstraZeneca: positive data in breast cancer -February 26, 2025 at 04:16 am EST - Marketscreener.com
AstraZeneca's camizestrant shows promise in breast cancer trial - ShareCast
AstraZeneca's Breast Cancer Treatment Shows Upbeat Interim Results in Ongoing Trial - Marketscreener.com
AstraZeneca therapy improves survival in late-stage breast cancer trial - Reuters.com
AstraZeneca therapy improves survival in late-stage breast cancer trial -February 26, 2025 at 02:37 am EST - Marketscreener.com
Astrazeneca, Vertex, Axsome secure US FDA approvals in January - BioWorld Online
Transcend Capital Advisors LLC Sells 5,397 Shares of AstraZeneca PLC (NASDAQ:AZN) - MarketBeat
AstraZeneca Pharma India ropes in Harish Dash as Senior Director, Commercial IT & Digital - Medical Dialogues
Constipation Treatment Market Is Booming Worldwide 2025-2032 | - openPR
AstraZeneca therapy improves survival in late-stage breast cancer trial -February 26, 2025 at 02:47 am EST - Marketscreener.com
AstraZeneca PLC (AZN): A High Growth Mega Cap Stock You Can Buy and Hold for the Next 5 Years - MSN
Asia Deal Watch: AstraZeneca Buys FibroGen’s Chinese Subsidiary - Citeline News & Insights
AstraZeneca PLC Investors: Please contact the Portnoy Law - GlobeNewswire
AstraZeneca PLC Investors: Please contact the Portnoy Law Firm to recover your losses. February 21, 2025 Deadline to file Lead Plaintiff Motion - TradingView
AstraZeneca PLC (LON:AZN) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):